Which Imaging Techniques Should Be Used at Diagnosis and to Monitor Treatment Efficacy?

Web Exclusives
Download Newsletter

In recent years, a better understanding of the biology and molecular pathology of multiple myeloma (MM) has resulted in significant therapeutic milestones. As the treatment of the disease continues to evolve, so do costs, prompting healthcare stakeholders to increasingly seek valuebased approaches to patient management. The goal of this newsletter series, published by the Association for Value-Based Cancer Care™, is to report on the latest clinical advances in myeloma and provide stakeholder perspectives on how emerging data can be used to promote high-quality, cost-effective care. Previous newsletters in this series (available at www.AVBCConline.org) discussed the importance of cytogenetic findings as they relate to therapeutic decision-making, and the selection of effective induction regimens for transplant-eligible and -ineligible patients with the disease. In this fourth newsletter, we will discuss imaging techniques used to evaluate bone disease in patients with MM.

Subscribe to Value-Based Care in Neurology

Stay up to date with the latest news in neurology by subscribing to receive the free VBCN e‑Newsletter.